The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

IMVT FINANCIAL STATEMENTS

Immunovant Inc — balance sheet, income statement and cash flow trends

IMVTImmunovant Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-400 M-200 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue7.1 M $Gross Profit6.9 M $ · 97%Operating Income-558.9 M $ · -7877%Pre-tax Income-538.9 M $ · -7596%Net Income to Owners-538.2 M $ · -7586%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue7.1 M $+4,334.4%
Gross Profit6.9 M $—
Operating Income-558.9 M $—
EBITDA-538.5 M $—
Net Income to Owners-538.2 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0500 M1 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets852.5 M
  • Equity735.4 M $86%
  • Current Liabilities117.1 M $14%

Key Figures

YoY change
Total Assets852.5 M $+28.9%
Total Liabilities117.1 M $+121.4%
Total Equity735.4 M $+20.8%
Cash & ST Investments797.8 M $+33.2%
Total Debt——
Net Debt-797.8 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-400 M-200 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-400 M-200 M0200 M-414.3 M $Operating-8 K $Investing612.9 M $Financing198.6 M $Net Change

Key Figures

YoY change
Operating Cash Flow-414.3 M $—
Capital Expenditures8 K $-98.6%
Free Cash Flow-414.3 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on IMVT

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.